SV Life Sciences closes fourth fund on $572m(2)

SV Life Sciences has closed its fourth fund on $572m, just under the £300m fund that Abingworth closed last month but far exceeding its original target of $400m.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this